Evidence map›Paper›PMID 40653798›Full record

ArticleScandinavian journal of immunology2025

Exploratory Study of CD10

Timo Michael Westermann, Joe Sendas, Alexander Sebastian Koller, Darko Jovanovski, Dominik Hüsken, Pascal Max Lucien Lessing, Birte Weber, Bernd Mühling, Andreas Liebold, David Alexander Christian Messerer and 2 more

Abstract read
In one paragraph

Article in Scandinavian journal of immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Exploratory Study of CD10Scandinavian journal of immunology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Timo Michael WestermannInstitute of Clinical and Experimental Trauma Immunology, University Hospital Ulm, Ulm, Germany.
Joe SendasInstitute of Clinical and Experimental Trauma Immunology, University Hospital Ulm, Ulm, Germany.
Alexander Sebastian KollerInstitute of Clinical and Experimental Trauma Immunology, University Hospital Ulm, Ulm, Germany.
Darko JovanovskiDepartment of Cardiothoracic and Vascular Surgery, University Hospital Ulm, Ulm, Germany.
Dominik HüskenInstitute of Clinical and Experimental Trauma Immunology, University Hospital Ulm, Ulm, Germany.
Pascal Max Lucien LessingInstitute of Clinical and Experimental Trauma Immunology, University Hospital Ulm, Ulm, Germany.
Birte WeberDepartment of Trauma Surgery and Orthopaedics, Goethe University Frankfurt, Frankfurt, Germany.
Bernd MühlingDepartment of Cardiothoracic and Vascular Surgery, University Hospital Ulm, Ulm, Germany.
Andreas LieboldDepartment of Cardiothoracic and Vascular Surgery, University Hospital Ulm, Ulm, Germany.
David Alexander Christian MessererInstitute for Transfusion Medicine, University Hospital Ulm, Ulm, Germany.ORCID https://orcid.org/0000-0002-0834-038X
Markus Huber-LangInstitute of Clinical and Experimental Trauma Immunology, University Hospital Ulm, Ulm, Germany.
Lisa WohlgemuthInstitute of Clinical and Experimental Trauma Immunology, University Hospital Ulm, Ulm, Germany.ORCID https://orcid.org/0000-0001-5795-812X

Funding

Deutsche Forschungsgemeinschaft 465409392
6 · The paper itself

Abstract

The lack of diagnostic and monitoring tools for postsurgical immunological complications such as systemic inflammation can contribute to a poor outcome despite modern intensive care. The need for reliable immune monitoring has been emphasised. Polymorphonuclear leukocytes (PMNs) play an important role in postsurgical inflammation. A subgroup of PMNs is particularly interesting, because they are released shortly after (iatrogenic) trauma: immature PMNs, characterised by, for example, their low CD10 expression. Therefore, we investigated the role of CD10

Indexed as

Cardiac Surgical ProceduresInflammationNeprilysinNeutrophilsPostoperative ComplicationsAgedBiomarkersExtracorporeal CirculationFemaleHumansInterleukin-6Lipocalin-2MaleMiddle AgedBiomarkersInterleukin-6Lipocalin-2Neprilysin

Identifiers

PMID40653798
PMCPMC12256972

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.